Loading fund overlap…
17 of 129 unique stocks in common · Jaccard: 13.2%
A weighted portfolio overlap of 9.93% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹9.93 is allocated to the exact same companies at the same relative proportions. The schemes share 17 common holdings.
The largest overlapping asset in their portfolios is Eternal, which commands a weight of 3.39% in HDFC Flexi Cap Fund and 1.65% in Kotak Mid Cap Fund. Holding both schemes increases your concentration in Eternal rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in HDFC | in Kotak |
|---|---|---|
| EternalRetailing | 3.39% | 1.65% |
| Persistent SystemsIT - Software | 1.34% | 1.59% |
| Max Healthcare InstituteHealthcare Services | 1.49% | 0.92% |
| Aster DM Quality CareHealthcare Services | 0.81% | 1.56% |
| Lenskart SolutionsRetailing | 0.70% | 0.95% |
| Bharat ElectronicsAerospace & Defense | 0.62% | 1.95% |
| Vishal Mega MartRetailing | 0.57% | 3.11% |
| Apollo Hospitals EnterpriseHealthcare Services | 0.68% | 0.56% |
| BSECapital Markets | 0.45% | 0.58% |
| Nippon Life India Asset ManagementCapital Markets | 0.38% | 1.56% |
| United SpiritsBeverages | 0.75% | 0.38% |
| Dixon Technologies (India)Consumer Durables | 0.32% | 2.60% |
| SwiggyRetailing | 0.27% | 1.64% |
| Apar IndustriesElectrical Equipment | 0.26% | 1.45% |
| BioconPharmaceuticals & Biotechnology | 0.26% | 1.07% |
| Hindustan Petroleum CorporationPetroleum Products | 0.23% | 1.19% |
| Rubicon ResearchPharmaceuticals & Biotechnology | 0.21% | 0.96% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Aug 2026). Equity holdings only, ISIN-verified. Not investment advice.